Literature DB >> 5645729

Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

A Lorber, R L Cohen, C C Chang, H E Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645729     DOI: 10.1002/art.1780110207

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  25 in total

1.  Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity.

Authors:  A E Koch; J C Burrows; P J Polverini; M Cho; S J Leibovich
Journal:  Agents Actions       Date:  1991-11

Review 2.  Clinical pharmacokinetics of oral and injectable gold compounds.

Authors:  K L Blocka; H E Paulus; D E Furst
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 3.  Monitoring gold plasma levels in rheumatoid arthritis.

Authors:  A Lorber
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

4.  Effects of gold salts and prednisolone on inflammatory cells. II. Suppression of inflammation and phagocytosis in the rat.

Authors:  B Vernon-Roberts; J D Jessop; J Doré
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

5.  Effects of gold salts and prednisolone on inflammatory cells. I. Phagocytic activity of macrophages and polymorphs in inflammatory exudates studied by a "skin-window" technique in rheumatoid and control patients.

Authors:  J D Jessop; B Vernon-Roberts; J Harris
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

6.  Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.

Authors:  J D Jessop; R G Johns
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

Review 7.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

8.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

9.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors:  A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

10.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.